{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:59:30Z","timestamp":1780477170350,"version":"3.54.1"},"update-to":[{"DOI":"10.1016\/j.jogoh.2021.102070","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000}}],"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jogoh.2021.102070","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T16:58:10Z","timestamp":1611161890000},"page":"102070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["RETRACTED: Therapeutic role of enoxaparin in intra-uterine growth restriction: A randomized clinical trial"],"prefix":"10.1016","volume":"50","author":[{"given":"Mahboobeh","family":"Shirazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Naeiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Rahimi","family":"Sharbaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Golshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrokh","family":"Sahebdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jogoh.2021.102070_bib0005","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/uog.13190","article-title":"Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)","volume":"42","author":"Lees","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"August (8)","key":"10.1016\/j.jogoh.2021.102070_bib0010","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1471-0528.2005.00656.x","article-title":"Customized birthweight centiles predict SGA pregnancies with perinatal morbidity","volume":"112","author":"McCowan","year":"2005","journal-title":"BJOG"},{"issue":"8","key":"10.1016\/j.jogoh.2021.102070_bib0015","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jgyn.2013.09.014","article-title":"Long-term outcome in context of intra uterine growth restriction and\/or small for gestational age newborns","volume":"42","author":"Gascoin","year":"2013","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"3","key":"10.1016\/j.jogoh.2021.102070_bib0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ajog.2007.06.038","article-title":"Small-for-gestational-age infants classified by customized or population birthweight centiles: impact of gestational age at delivery","volume":"197","author":"Groom","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.jogoh.2021.102070_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2431-4-9","article-title":"Comparisons of mortality and pre-discharge respiratory outcomes in small-for-gestational-age and appropriate-for-gestational-age premature infants","volume":"8","author":"Sharma","year":"2004","journal-title":"BMC Pediatr"},{"issue":"5","key":"10.1016\/j.jogoh.2021.102070_bib0030","first-page":"490","article-title":"Activation of coagulation in amniotic fluid during normal human pregnancy","volume":"128","author":"Sarig","year":"2011","journal-title":"Thromb Res"},{"issue":"12","key":"10.1016\/j.jogoh.2021.102070_bib0035","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/14767050802361872","article-title":"Tissue factor and its natural inhibitor in pre-eclampsia and SGA","volume":"21","author":"Erez","year":"2008","journal-title":"Matern Fetal Neonatal Med."},{"key":"10.1016\/j.jogoh.2021.102070_bib0040","series-title":"World Health Organization model list of essential medicines: 21st list 2019","author":"World Health Organization","year":"2019"},{"issue":"3","key":"10.1016\/j.jogoh.2021.102070_bib0045","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.pcl.2004.01.001","article-title":"Drugs that affect the fetus and newborn infant via the placenta or breast milk","volume":"51","author":"Ostrea","year":"2004","journal-title":"Pediatr Clin North Am"},{"issue":"3 Suppl","key":"10.1016\/j.jogoh.2021.102070_bib0050","doi-asserted-by":"crossref","first-page":"627S","DOI":"10.1378\/chest.126.3_suppl.627S","article-title":"Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Bates","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jogoh.2021.102070_bib0055","series-title":"\u201cEnoxaparin sodium injection label\u201d (PDF)","year":"2018"},{"issue":"9","key":"10.1016\/j.jogoh.2021.102070_bib0060","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-0528.2000.tb11110.x","article-title":"Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy","volume":"107","author":"Ellison","year":"2000","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.jogoh.2021.102070_bib0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.jogoh.2021.102070_bib0070","article-title":"Low molecular weight heparins use in pregnancy: a practice survey from Greece and a review of the literature","volume":"17","author":"Papadakis","year":"2019","journal-title":"Thromb J"},{"issue":"6 Suppl","key":"10.1016\/j.jogoh.2021.102070_bib0075","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: american College of Chest physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jogoh.2021.102070_bib0080","series-title":"Hypertension in pregnancy","author":"American College of Obstetricians and Gynecologists","year":"2013"},{"key":"10.1016\/j.jogoh.2021.102070_bib0085","series-title":"WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia","author":"World Health Organization","year":"2011"},{"issue":"4","key":"10.1016\/j.jogoh.2021.102070_bib0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.semperi.2008.04.007","article-title":"Fetal Doppler: Umbilical artery, middle cerebral artery, and venous system","volume":"32","author":"Mari","year":"2008","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jogoh.2021.102070_bib0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1196\/annals.1365.027","article-title":"Doppler assessment of the intrauterine growth-restricted fetus","volume":"1092","author":"Botsis","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.jogoh.2021.102070_bib0100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1515\/jpm-2013-0227","article-title":"Maternal serum placental growth factor and fetal SGA in pregnancy complicated by type 1 diabetes mellitus","volume":"42","author":"Gutaj","year":"2014","journal-title":"J Perinat Med"},{"issue":"2","key":"10.1016\/j.jogoh.2021.102070_bib0105","first-page":"165","article-title":"Predictive factors for intrauterine growth restriction","volume":"7","author":"Albu","year":"2014","journal-title":"J Med Life"},{"issue":"4","key":"10.1016\/j.jogoh.2021.102070_bib0110","first-page":"BE01","article-title":"Role of biomarkers in early detection of preeclampsia","volume":"8","author":"Kar","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.jogoh.2021.102070_bib0115","doi-asserted-by":"crossref","first-page":"e029467","DOI":"10.1136\/bmjopen-2019-029467","article-title":"Pharmacological interventions for the prevention of fetal growth restriction: protocol for a systematic review and network meta-analysis","volume":"9","author":"Bettiol","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.jogoh.2021.102070_bib0120","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.AOG.0000128902.84876.d4","article-title":"Effects of low-molecular-weight and unfractionated heparin on trophoblast function","volume":"104","author":"Quenby","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jogoh.2021.102070_bib0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajog.2004.09.029","article-title":"Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure","volume":"192","author":"Bose","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.jogoh.2021.102070_bib0130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ajog.2017.01.014","article-title":"Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial","volume":"216","author":"Groom","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.jogoh.2021.102070_bib0135","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/AOG.0000000000001673","article-title":"Enoxaparin and aspirin compared with aspirin alone to prevent placenta-mediated pregnancy complications: a randomized controlled trial","volume":"128","author":"Haddad","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jogoh.2021.102070_bib0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/AOG.0000000000002380","article-title":"Angiogenic factor profiles in pregnant women with a history of early-onset severe preeclampsia receiving low-molecular-Weight heparin prophylaxis","volume":"131","author":"Lecarpentier","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2021.102070_bib0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2018.08.006","article-title":"Tinzaparin for the treatment of foetal growth retardation: an open-labelled randomized clinical trial","volume":"170","author":"Hansen","year":"2018","journal-title":"Thromb Res"},{"issue":"9","key":"10.1016\/j.jogoh.2021.102070_bib0150","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ultrasmedbio.2006.05.030","article-title":"Low-molecular-weight heparin improves the performance of uterine artery Doppler velocimetry to predict preeclampsia and small-for-gestational age infant in women with gestational hypertension","volume":"32","author":"Torricelli","year":"2006","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"10.1016\/j.jogoh.2021.102070_bib0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/01.HYP.0000149950.05182.a3","article-title":"Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women","volume":"45","author":"Mello","year":"2005","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.jogoh.2021.102070_bib0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12325-019-01124-z","article-title":"Safety and efficacy of enoxaparin in pregnancy: a systematic review and meta-analysis","volume":"37","author":"Jacobson","year":"2020","journal-title":"Adv Ther"}],"updated-by":[{"DOI":"10.1016\/j.jogoh.2025.102984","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000}},{"DOI":"10.1016\/j.jogoh.2021.102070","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000}}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246878472100012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246878472100012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T17:47:21Z","timestamp":1749577641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246878472100012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S246878472100012X"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2021.102070","relation":{"retraction":[{"id-type":"doi","id":"10.1016\/j.jogoh.2021.102070","asserted-by":"object"}]},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Therapeutic role of enoxaparin in intra-uterine growth restriction: A randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2021.102070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102070"}}